Multiple Myeloma Targeted Medicine
Revlimid
Lenalidomide
Pomalyst
Pomalidomide
Velcade
Bortezomib
Ninlaro
Ixazomib
Kyprolis
Carfilzomib
Darzalex
Daratumumab
Darzalex Faspro
Daratumumab / Hyaluronidase-fihj
Sarclisa
Isatuximab-irfc
Empliciti
Elotuzumab
Xpovio
Selinexor
Blenrep
Belantamab Mafodotin-blmf
Nplate
Romiplostim
Promacta
Eltrombopag
Talvey
Talquetamab-tgvs
Tecvayli
Teclistamab-cqyv
Elrexfio
Elranatamab-bcmm
Abecma
Idecabtagene Vicleucel
Carvykti
Ciltacabtagene Autoleucel
Yescarta
Axicabtagene Ciloleucel
Isatuximab Combo
Isatuximab / Carfilzomib / Dexamethasone
Bortezomib Combo
Bortezomib / Melphalan / Prednisone
Bendeka
Bendamustine Hydrochloride
Thalomid
Thalidomide
Cytoxan
Cyclophosphamide
Velcade + Dex
Bortezomib / Dexamethasone
Melphalan
Melphalan Hydrochloride
Synribo
Omacetaxine Mepesuccinate
Venclexta
Venetoclax
Revuforj
Revumenib
Trisenox
Arsenic Trioxide
Farydak
Panobinostat
KRd Regimen
Carfilzomib / Lenalidomide / Dexamethasone
IRd Regimen
Ixazomib / Lenalidomide / Dexamethasone
Xospata
Gilteritinib
Daurismo
Glasdegib
Elotuzumab Combo
Elotuzumab / Lenalidomide / Dexamethasone
Daratumumab SC
Daratumumab / Hyaluronidase-fihj
Isatuximab IV
Isatuximab-irfc
VRd Regimen
Bortezomib / Lenalidomide / Dexamethasone
Bortezomib + Dex
Bortezomib / Dexamethasone